Does RUXOLITINIB Cause Facial paralysis? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Facial paralysis have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.0% of all adverse event reports for RUXOLITINIB.
26
Reports of Facial paralysis with RUXOLITINIB
0.0%
of all RUXOLITINIB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Facial paralysis From RUXOLITINIB?
Of the 26 reports, 13 (50.0%) required hospitalization, and 2 (7.7%) were considered life-threatening.
Is Facial paralysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Facial paralysis?
ADALIMUMAB (382)
ONABOTULINUMTOXINA (305)
METHOTREXATE (304)
NIVOLUMAB (171)
ETANERCEPT (169)
RITUXIMAB (151)
SECUKINUMAB (140)
PREDNISONE (139)
ASPIRIN (127)
FINGOLIMOD (121)
Which RUXOLITINIB Alternatives Have Lower Facial paralysis Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE